[HTML][HTML] Exercise in the management of metabolic-associated fatty liver disease (MAFLD) in adults: A position statement from exercise and sport science Australia

SE Keating, A Sabag, K Hallsworth, IJ Hickman… - Sports Medicine, 2023 - Springer
Metabolic-associated fatty liver disease (MAFLD) is the most prevalent chronic liver disease
worldwide, affecting 25% of people globally and up to 80% of people with obesity. MAFLD is …

Exercise in the Management of Metabolic-Associated Fatty Liver Disease (MAFLD) in Adults: A Position Statement from Exercise and Sport Science Australia

SE Keating, A Sabag, K Hallsworth, IJ Hickman… - Sports …, 2023 - pure.psu.edu
Metabolic-associated fatty liver disease (MAFLD) is the most prevalent chronic liver disease
worldwide, affecting 25% of people globally and up to 80% of people with obesity. MAFLD is …

Exercise in the Management of Metabolic-Associated Fatty Liver Disease (MAFLD) in Adults: A Position Statement from Exercise and Sport Science Australia.

SE Keating, A Sabag, K Hallsworth… - Sports Medicine …, 2023 - europepmc.org
Metabolic-associated fatty liver disease (MAFLD) is the most prevalent chronic liver disease
worldwide, affecting 25% of people globally and up to 80% of people with obesity. MAFLD is …

[引用][C] Exercise in the Management of Metabolic-Associated Fatty Liver Disease (MAFLD) in Adults: A Position Statement from Exercise and Sport Science Australia

SE Keating, A Sabag, K Hallsworth… - Sports …, 2023 - espace.library.uq.edu.au
Metabolic-associated fatty liver disease (MAFLD) is the most prevalent chronic liver disease
worldwide, affecting 25% of people globally and up to 80% of people with obesity. MAFLD is …

Exercise in the Management of Metabolic-Associated Fatty Liver Disease (MAFLD) in Adults: A Position Statement from Exercise and Sport Science Australia

SE Keating, A Sabag, K Hallsworth… - Sports medicine … - pubmed.ncbi.nlm.nih.gov
Metabolic-associated fatty liver disease (MAFLD) is the most prevalent chronic liver disease
worldwide, affecting 25% of people globally and up to 80% of people with obesity. MAFLD is …

Exercise in the management of metabolic-associated fatty liver disease (MAFLD) in adults: a position statement from exercise and sport science Australia

SE Keating, A Sabag, K Hallsworth… - Sports …, 2023 - researchdirect.westernsydney.edu …
Metabolic-associated fatty liver disease (MAFLD) is the most prevalent chronic liver disease
worldwide, affecting 25% of people globally and up to 80% of people with obesity. MAFLD is …

[HTML][HTML] Exercise in the Management of Metabolic-Associated Fatty Liver Disease (MAFLD) in Adults: A Position Statement from Exercise and Sport Science Australia

SE Keating, A Sabag, K Hallsworth… - Sports Medicine …, 2023 - ncbi.nlm.nih.gov
Metabolic-associated fatty liver disease (MAFLD) is the most prevalent chronic liver disease
worldwide, affecting 25% of people globally and up to 80% of people with obesity. MAFLD is …

Exercise in the Management of Metabolic-Associated Fatty Liver Disease (MAFLD) in Adults: A Position Statement from Exercise and Sport Science Australia

SE Keating, A Sabag, K Hallsworth, IJ Hickman… - Sports …, 2023 - eprints.ncl.ac.uk
Exercise in the Management of Metabolic-Associated Fatty Liver Disease (MAFLD) in Adults: A
Position Statement from Exercise and Sport Science Australia - ePrints - Newcastle University …

Exercise in the management of Metabolic-Associated Fatty Liver Disease (MAFLD) in Adults: A position statement from Exercise and Sport Science Australia

SE Keating, A Sabag, K Hallsworth, IJ Hickman… - 2023 - wslhd.intersearch.com.au
Metabolic-associated fatty liver disease (MAFLD) is the most prevalent chronic liver disease
worldwide, affecting 25% of people globally and up to 80% of people with obesity. MAFLD is …

Exercise in the Management of Metabolic-Associated Fatty Liver Disease (MAFLD) in Adults: A Position Statement from Exercise and Sport Science Australia.

SE Keating, A Sabag, K Hallsworth… - Sports Medicine …, 2023 - europepmc.org
Metabolic-associated fatty liver disease (MAFLD) is the most prevalent chronic liver disease
worldwide, affecting 25% of people globally and up to 80% of people with obesity. MAFLD is …